Sledge GW - Search Results

1

Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes.

Schneider BP, Skaar TC, Sledge GW, Badve S, Li L, Flockhart DA. Schneider BP, et al. Among authors: sledge gw. Breast Cancer Res Treat. 2006 Apr;96(3):209-15. doi: 10.1007/s10549-005-9003-0. Epub 2006 Feb 28. Breast Cancer Res Treat. 2006. PMID: 16505966

2

Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease.

Olivarez D, Ulbright T, DeRiese W, Foster R, Reister T, Einhorn L, Sledge G. Olivarez D, et al. Cancer Res. 1994 May 15;54(10):2800-2. Cancer Res. 1994. PMID: 7513256

3

Effects of tetracyclines on angiogenesis in vitro.

Fife RS, Sledge GW Jr, Sissons S, Zerler B. Fife RS, et al. Among authors: sledge gw jr. Cancer Lett. 2000 May 29;153(1-2):75-8. doi: 10.1016/s0304-3835(00)00348-7. Cancer Lett. 2000. PMID: 10779633

4

Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.

Nozaki S, Sledge GW Jr, Nakshatri H. Nozaki S, et al. Among authors: sledge gw jr. Biochem Biophys Res Commun. 2000 Aug 18;275(1):60-2. doi: 10.1006/bbrc.2000.3241. Biochem Biophys Res Commun. 2000. PMID: 10944441

5

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Sweeney CJ, Miller KD, Sissons SE, Nozaki S, Heilman DK, Shen J, Sledge GW Jr. Sweeney CJ, et al. Among authors: sledge gw jr. Cancer Res. 2001 Apr 15;61(8):3369-72. Cancer Res. 2001. PMID: 11309294

6

Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.

Sledge GW Jr. Sledge GW Jr. Semin Oncol. 2002 Jun;29(3 Suppl 11):104-10. doi: 10.1053/sonc.2002.34062. Semin Oncol. 2002. PMID: 12138404 Review.

7

The HERstory of breast cancer revealed.

Sledge GW Jr. Sledge GW Jr. Clin Breast Cancer. 2003 Dec;4(5):308. doi: 10.3816/cbc.2003.n.036. Clin Breast Cancer. 2003. PMID: 14715104 No abstract available.

8

Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine.

Nozaki S, Maeda M, Tsuda H, Sledge GW Jr. Nozaki S, et al. Among authors: sledge gw jr. Breast Cancer Res Treat. 2004 Feb;83(3):195-9. doi: 10.1023/B:BREA.0000013996.49528.d8. Breast Cancer Res Treat. 2004. PMID: 14758089 Free article.

9

Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.

Miller KD, Soule SE, Calley C, Emerson RE, Hutchins GD, Kopecky K, Badve S, Storniolo A, Goulet R, Sledge GW Jr. Miller KD, et al. Among authors: sledge gw jr. Breast Cancer Res Treat. 2005 Jan;89(2):187-97. doi: 10.1007/s10549-004-2044-y. Breast Cancer Res Treat. 2005. PMID: 15692762 Clinical Trial.

10

Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'.

Lippman ME, Benz C, Chinnaiyan A, Flockhart D, Harris A, Hudis C, Osborne CK, Press MF, Rae J, Sledge GW, Van't Veer L, Wicha M. Lippman ME, et al. Among authors: sledge gw. Breast Cancer Res Treat. 2005 Mar;90(1):1-3. doi: 10.1007/s10549-004-1288-x. Breast Cancer Res Treat. 2005. PMID: 15770520 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page